Search results - ORA - Oxford University Research Archive

« Previous | 1 - 20 of 256 | Next »

1

Journal article

Age, depositional history and tectonics of the Indo-Myanmar Ranges, Myanmar

Naing, TT, Robinson, S, Searle, M, et al.
2023

2

Journal article

Demonstration of better superconducting performance in a solder with low lead content

Aksoy, C, Cakir, B, Koparan, ET, et al.
2022-12-05

3

Journal article

A rational inattention unemployment trap

Ellison, M, Macaulay, A
2021-09-09

4

Journal article

Recent advances in reinforcement learning in finance

Hambly, B, Xu, R, Yang, H
2023

5

Thesis

Characterising dynamical systems models of tumour-immune interactions

Osojnik, A
2021

6

Journal article

Synergistic surface modification of tin-lead perovskite solar cells

Hu, S, Zhao, P, Nakano, K, et al.
2023-01-22

7

Journal article

National Qualifications in Scotland: a lightning rod for public concern about equity in pandemic

Hayward, L, Baird, J-A
2022

8

Thesis

The role of TIRR in DNA damage and repair

Ketley, R
2022

9

Thesis

National heritage in private hands: the political and cultural status of country houses in Britain, 1950-2000

Porter, E
2022

10

Journal article

Mill before Liberalism (II)

Ghosh, P
2023

11

Journal article

Mill before liberalism (I)

Ghosh, P
2023

12

Journal article

Autoimmunity-associated T cell receptors recognize HLA-B*27-bound peptides

Yang, X, Garner, LI, Zvyagin, IV, et al.
2022-12-07

13

Journal article

Developing the path signature methodology and its application to landmark-based human action recognition

Yang, W, Lyons, T, Ni, H, et al.
2022-04-22

14

Conference item

A phase 3, randomized, open-label study evaluating the safety and efficacy of magrolimab in combination with azacitidine in previously untreated patients with TP53-mutant acute myeloid leukemia

Daver, N, Vyas, P, Chao, MP, et al.
2022-10-13

15

Conference item

Magrolimab in combination with azacitidine for patients with untreated higher-risk myelodysplastic syndromes: 5F9005 phase 1b study results

Sallman, DA, Al Malki, MM, Asch, AS, et al.
2022-10-13

16

Conference item

MDS-445 Magrolimab in combination with azacitidine for patients with untreated higher-risk myelodysplastic syndromes (HR MDS): 5F9005 phase 1b study results

Sallman, D, Malki, MA, Asch, A, et al.
2022-09-21

17

Conference item

AML-348 A phase Ib/II study of ivosidenib with venetoclax +/- azacitidine in IDH1-mutated hematologic malignancies

Lachowiez, C, Borthakur, G, Loghavi, S, et al.
2022-09-21

18

Journal article

An asymptotic radius of convergence for the Loewner equation and simulation of SLEκ traces via splitting

Foster, J, Lyons, T, Margarint, V
2022-09-03

19

Conference item

AML-432 Overall survival (OS) by IDH2 mutant allele (R140 or R172) in patients with late-stage, mutant-IDH2 relapsed/refractory acute myeloid leukemia (AML) treated with enasidenib or conventional care regimens (CCR) in the randomized, open-label, Phase 3 IDHENTIFY Trial

DiNardo, CD, de Botton, S, Risueño, A, et al.
2022-09-21

20

Conference item

AML-464 Tolerability and efficacy of the first-in-class anti-CD47 antibody magrolimab combined with azacitidine in frontline patients with TP53-mutated acute myeloid leukemia (AML): Phase 1b results

Daver, N, Vyas, P, Kambhampati, S, et al.
2022-09-21

« Previous
1
2
3
4
5
…
12
13
Next »

TO TOP